A cross-party group of Dunfermline Councillors tried to navigate around obstacles and clutter on the streets of Dunfermline on the morning of Friday, November 24th wearing spectacles that mimic different sight loss conditions.
Up to 12 CPD points on offer as SpaMedica hosts its 2023 Optometry Conference at The Bristol Pavilion on 26 November.
Sight-saving specialist Newmedica has officially opened a multimillion-pound clinic for the people of Hampshire.
Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.
The Association of Ophthalmic Nurses and Technicians (AONT) is an independent professional network for ophthalmic nurses and technicians created with a vision to support and enhance care through greater awareness of new roles, resources, and education.
Dr Sancy Low, Consultant Ophthalmic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’.
Following an internationally successful Randomised Controlled Trial (RCT) comparing the Direct Selective Laser Trabeculoplasty (DSLT) with standard SLT, the first ever commercial device in the UK, the ‘Eagle’, has been installed and is in use at Moorfields Eye Hospital in London.
Glaucoma UK announces the Open Call Research Award 2023, offering up to £50,000 in funding for glaucoma-related research.
Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.
Glaucoma UK, the Muslim Council of Britain (MCB), and the British Islamic Medical Association (BIMA) are encouraging Muslims with glaucoma to continue using their medication as prescribed during the holy month to prevent irreversible sight loss.